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INTRODUCTION 
 
Acute Myocardial Infarction is one of the leading causes of death among 
men and women worldwide. Most of the early deaths are due to Ventricular 
Arrhythmias. These Arrhythmias are responsible for the sudden deaths 
associated with Myocardial Infarction. The late mortality associated with 
Myocardial Infarction is typically due to left ventricular dysfunction and its 
complications. Residual Left Ventricular function after Myocardial Infarction is 
an important prognostic marker. 
Left Ventricular dysfunction can be systolic, diastolic or both. 
Echocardiography is the most widely used and readily available, non-invasive 
tool in the arsenal of cardiologist for evaluating the left ventricular function. 
Echocardiographic evaluation of Left Ventricular function is an integral part of 
evaluation of a patient with Acute Myocardial Infarction. Two – Dimensional 
echocardiography is useful for the assessment of systolic function, and Doppler 
Echocardiography is well suited for studies of diastolic function. 
An acute Trans-mural Myocardial Infarction causes a loss of contractile 
fibres which reduces systolic function. Parallel to the effect on systolic function, 
a myocardial infarction also impacts diastolic function, as evidenced by the 
raise in left ventricular end diastolic pressure. 
This study is performed to estimate the prevalence of left ventricular 
systolic and diastolic dysfunction using various Echocardiographic indices in 
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patients with Acute ST elevation Myocardial Infarction and to find out its 
significance in determining early in-hospital morbidity, especially early 
Congestive Heart Failure in such patients.  
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AIMS AND OBJECTIVES OF THE STUDY 
 
1) To assess the prevalence of Left Ventricular Systolic and Diastolic 
dysfunction in patients with Acute Myocardial Infarction. 
 
2) To study the association between Left Ventricular Systolic, Diastolic 
dysfunction and the variables such as Age, Sex, Smoking, Diabetes, 
Hypertension, Killip Class, Type of Myocardial Infarction. 
 
3) To assess the relationship between the echocardiographic indices of systolic 
and diastolic function and the development of early in-hospital congestive heart 
failure (as defined by Killip Class ≥ II). 
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REVIEW OF LITERATURE 
 
Acute ST Elevation Myocardial Infarction – an overview 
Despite the advances made in the diagnosis and management of ST 
Elevation Myocardial Infarction (STEMI), it continues to be a major public 
health problem in the industrialized world as well as in developing countries 
like India.
 [1]
 It has been estimated that the number of years of life lost because 
of an AMI is 15 years. The burden of Myocardial Infarction in developing 
countries is approaching those now afflicting developed countries. The scarcity 
of available resources to treat ST Elevation Myocardial Infarction (STEMI) in 
developing countries mandate major efforts on an international level to 
strengthen primary prevention programs.
[2] 
Mortality from STEMI has declined steadily over the past few decades.
[3]
 
This drop in mortality appears to result from a fall in the incidence of STEMI 
which is replaced in part by an increase in the rate of Unstable 
Angina(UA)/non–ST-segment elevation Myocardial Infarction (NSTEMI)[4] and 
a fall in the case fatality rate of STEMI patients.
[5] 
Although reperfusion has 
made important progress in lowering mortality, many patients with acute MI are 
not eligible for this therapy and face in-hospital death rates of 10% to 20%.
[6] 
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Historical phases in the evolution of coronary care 
There have been several phases in the management of patients with 
STEMI. These phases have contributed to the gradual decline in mortality from 
STEMI.
[7]
 In the first half of the 20
th
 century, management of STEMI focussed 
on a detailed recording of physical and laboratory findings, with little active 
treatment for the infarction. This phase is known as the ―clinical observation 
phase‖ of coronary care. The ―coronary care unit phase‖ began in the mid-1960s 
and included detailed analysis and vigorous management of cardiac 
arrhythmias. The ―high-technology phase‖ began with the introduction of the 
pulmonary artery balloon flotation catheter. It helped in the bedside 
hemodynamic monitoring and more precise hemodynamic management of 
STEMI patients. The modern ―reperfusion era‖ of coronary care heralded the 
introduction of intracoronary and then intravenous fibrinolysis, increased use of 
aspirin, and the development of primary percutaneous coronary intervention. 
Contemporary care of patients with STEMI has entered an evidence-based 
coronary care phase where we are increasingly using standard guidelines and 
performance measures for clinical practice.
[8]
  
Acute myocardial infarction (AMI) results in local myocyte damage that 
leads to systolic and diastolic dysfunction. Following a myocardial infarction 
various physiological and pathophysiological process are set in motion. Some of 
them are left ventricular (LV) remodelling, local and systemic neurohormonal 
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activation, and vascular dysfunction. LV systolic dysfunction, its 
pathophysiology and prognosis after AMI have been extensively researched for 
several decades. Either clinical or radiographic evidence of heart failure has 
been found to be a powerful predictor of outcome in patients after AMI, in 
addition to depressed systolic function.
[9]
 Pulmonary congestion after infarction 
has been attributed to raised LV filling pressures but it may be seen after what 
appears to be only minor myocardial damage.
[10]
 The pathophysiological basis 
for raised filling pressures is incompletely understood but may involve impaired 
active relaxation of the myocardium  and increased LV chamber stiffness. These 
abnormalities constitute what is known as diastolic dysfunction. 
Definition and Clinical evaluation of patients with myocardial infarction 
 Acute Myocardial infarction (AMI) can be defined from a number of 
different perspectives related to clinical, electrocardiographic 
(ECG),
 
biochemical and pathologic characteristics. The gold standard for 
diagnosing myocardial infarction has been the World Health Organization 
definition,
 [11]
 which requires any 2 of 3 criteria:  
1. Ischemic symptoms,  
2. Elevated creatine kinase-MB levels, and 
3. Electrocardiographic changes. 
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Recently, a new definition that for the first time which includes elevated 
troponin levels have been published by the American College of Cardiology and 
the European Society of Cardiology published.
 
 
Clinical Features 
The classic symptoms of MI are intense, oppressive, durable, excruciating 
chest pressure, with an impending sense of doom and radiation of the pain to the 
left arm. However, the other symptoms of chest heaviness or burning, radiation 
to the jaw, neck, shoulder, back, or both arms may be encountered. The 
discomfort is not
 
affected by moving the muscles of the region where the 
discomfort
 
is located, nor is it worsened by respiratory movements and not 
positional in nature. The discomfort associated with acute MI usually
 
lasts at 
least 20 min, but may be shorter in duration. The pain is usually sustained, but 
can be stuttering.  Nausea and Vomiting are frequently encountered in inferior 
wall myocardial infarction. Another typical finding is profuse diaphoresis. On 
the whole, the classical presentation is experiencing a unique, discrete, painful 
event that has induced fear. However, exceptions to the classical presentation 
are common and are more challenging. It is imperative to ask whether there 
were premonitory signs of chest discomfort in the preceding week or two. Other 
associated risk factors, such as smoking, elevated cholesterol, diabetes, 
hypertension, and family history, when present, give us a supportive piece that 
helps to put the acute history into context. Dyspnea, when present denotes 
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incipient congestive heart failure or, alternatively, is an outgrowth of the 
patient's anxiety. Palpitations or syncope are quite uncommon, but a history of 
light-headedness or dizziness and presyncope often reflects the underlying 
vagotonia or bradyarrhythmias seen in inferior wall myocardial infarction. 
Ventricular tachycardia may produce syncope or an out-of-hospital arrest. 
Although most of the patients have symptoms just described,
 
these 
complaints may go unrecognized or may be erroneously labelled
 
as another 
disease entity, such as peptic ulcer disease.
 
Myocardial necrosis may also occur 
without symptoms; it may
 
be detected only by the Electrocardiogram, raised 
cardiac enzymes or other imaging studies. 
Risk stratification of patients with Acute Myocardial Infarction 
The physical examination also provides a method for the risk 
stratification of STEMI patients. The Killip classification (shown in the table) 
can be used as a method to stratify patients and predict clinical outcomes.
[9]
 The 
Killip  classification originally devised in the 1960’s has stood the test of  time 
and has been shown in several studies to accurately predict clinical outcomes 
following Acute Myocardial Infarction. With modern therapy, the mortality of 
those in cardiogenic shock has improved from 83% (at the time the study was 
done) to approximately 60% now. 
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* 
Has improved to approximately 60% with current therapy. 
Clinical classification of Myocardial Infarction
 [12]
 
 
Table adapted from Thygeson et al
[12]
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The Joint Task Force of the European Society of Cardiology, American 
College of Cardiology Foundation, the American Heart Association, and the 
World Health Federation (ESC/ACCF/AHA/WHF) in 2007, has proposed the 
above clinical classification of myocardial infarction. 
Echocardiography in Patients with Acute Myocardial Infarction  
Echocardiography has several important roles, in patients with AMI:  
(1) Diagnosis and exclusion of acute MI in patients with prolonged chest 
pain and non-diagnostic electrocardiographic findings;  
(2) Estimation of the amount of myocardium at risk and final infarct size 
after reperfusion therapy;  
(3) Evaluation of patients with unstable hemodynamic findings and 
detection of infarct complications;  
(4) Evaluation of myocardial viability; and  
(5) Risk stratification. 
Two-dimensional echocardiographic imaging is helpful in assessing 
reperfused myocardial segments or infarct expansion in patients with STEMI. 
When the segments are persistently akinetic, it does not always indicate failed 
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reperfusion. If the myocardium remains akinetic while being viable, dobutamine 
stress echocardiography is helpful to demonstrate its viability.
[13,14]
  
Detection of Mechanical Complications of Acute Myocardial Infarction  
The mechanical complications of Myocardial Infarction can be life-
threatening. Hence it is imperative that reliable and timely identification is 
critical for optimal management. In a patient with suspected mechanical 
complication or with unstable hemodynamics, Two-dimensional (2D) and 
Doppler echocardiography with colour flow imaging is generally the first 
imaging modality used. TEE (Transesophageal Echocardiogram) is of immense 
utility for patients in whom precordial echocardiography is not possible for 
various reasons. TEE can be used under the most difficult clinical situations, 
including in the critical care unit, in intubated patients and postoperative 
patients, and even during cardiopulmonary resuscitation.
[15]
 Mechanical 
complication should be suspected when a critically ill or hemodynamically 
unstable patient has normal systolic function.  
 
Evaluation of Systolic and Diastolic Function  
Systolic Functional Parameters  
The systolic parameters measured by Echocardiography that are used as a 
marker for left ventricular systolic function of the heart are  Left Ventricular 
Ejection Fraction (LVEF), stroke volume and cardiac index, systolic tissue 
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velocity of the mitral annulus, fractional shortening, strain, and regional wall 
motion analysis. 
Left Ventricular Ejection Fraction  
The most commonly used and universally accepted expression of global 
LV function is Left Ventricular Ejection Fraction (LVEF). Although LVEF has 
many limitations, including operator dependency, it is a strong predictor of 
clinical outcome in many cardiac conditions. LVEF is also used to select 
optimal management strategies. In clinical practice, LVEF is usually determined 
by visual assessment of two-dimensional echocardiographic images of the left 
ventricle. This method is reasonably reliable when it is performed by an 
experienced echocardiographer but varies widely among readers. Hence it is 
advisable that, LVEF should be measured more objectively whenever possible, 
using volumetric measurements as described by the following equation:  
      
              
     
 
where LVEDV and LVESV are LV end-diastolic volume and end-
systolic volume, respectively. 
M-mode or two-dimensional echocardiography are used to measure LV 
dimensions and LVEF can also be calculated from these values. The following 
formula is used to calculate LVEF from the M-mode or two-dimensional 
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echocardiographic measurement of LV dimensions from the mid-ventricular 
level:   
      
                
      
 
  
Where LVEDD and LVESD are end-diastolic diameter and end-systolic 
diameter, respectively.  
This equation is actually calculates the percentage change in LV area, or 
fractional shortening of the LV short axis, which equals LVEF if the apical 
long-axis dimension remains the same from diastolic phase to systolic 
contraction. Since the apical long axis normally shortens 10% to 15% with 
systole, an apical correction factor is added on the basis of the contractility of 
the apex: 5% to 7% for normal to hyperdynamic apical contraction, 3% for 
hypokinetic contraction, and 0% for akinetic apex. 
Three-dimensional (3D) echocardiography is likely to become the 
standard method to calculate the LVEF, because it can provide LV end-diastolic 
and end-systolic volumes closer to those measured by Cardiac Magnetic 
Resonance (CMR). The synchronicity of LV regional contraction can also be 
assessed by 3D Echocardiography, as it can also provide regional LV volume as 
well as the timing of the smallest volume of each region. 
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Fractional Shortening  
Fractional shortening (FS) is the percentage change in LV dimensions 
with each LV contraction. This systolic function parameter is now rarely used 
for diagnosis or clinical decision making. 
    
              
     
 
 
Stroke Volume  
Stroke volume (SV) can be measured as the difference between LVEDV 
and LVESV obtained by the Simpson method or three-dimensional 
echocardiography. The difference will be equal to systolic volume across the 
LVOT (Left Ventricular Outflow Tract) if there is no valvular regurgitation. 
When there is mitral regurgitation (MR), regurgitant volume needs to be 
subtracted to obtain Stroke Volume across LVOT. The product of LVOT area 
and LVOT time-velocity integral also give the LVOT Stroke Volume. 
Systolic Velocity of Myocardial Tissue or Mitral Annulus   
  Tissue Doppler Echocardiography is used to measure the systolic 
component of the mitral annulus. There is good correlation between LVEF and 
Systolic Velocity of Myocardial Tissue and is a good predictor of outcome in 
many cardiac disorders.
[16] 
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Regional Wall Motion Scoring Index (RWMI) 
Regional wall motion analysis is the most commonly used 
echocardiographic parameter to evaluate coronary artery disease. It is one of the 
most common uses of echocardiography.  
From the parasternal, apical, and sometimes subcostal imaging windows, 
two-dimensional echocardiography can visualize all LV wall segments. For 
purposes of regional wall motion analysis, the ASE has recommended a 16-
segment model or, optionally, a 17-segment model with an addition of the 
apical cap. The following numerical score is assigned to each wall segment on 
the basis of its contractile function as assessed visually:  
1 = normal (>40% thickening with systole);  
2 = hypokinesis (10% to 40% thickening);  
3 = severe hypokinesis to akinesis (<10% thickening);  
4 = dyskinesis; and  
5 = aneurysm.  
On the basis of this wall motion analysis scheme, a wall motion score 
index (WMSI) is calculated to semiquantitate the extent of regional wall motion 
abnormalities: 
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A normal left ventricle has a WMSI of 1, and the index increases as wall 
motion abnormalities become more severe. When two-dimensional 
echocardiography was performed simultaneously with sestamibi SPECT in 
patients with acute ST-segment MI (STEMI), the overall correlation between 
the WMSI and the perfusion defect was good. Patients with WMSI higher than 
1.7 tend to have a perfusion defect greater than 20%. The correlation is usually 
better for patients with an anterior wall MI than for those with an inferior or 
lateral wall MI with a smaller infarct size. A small area of subendocardial 
ischemia may not demonstrate wall motion abnormality, but contrast 
echocardiography can demonstrate a rim of subendocardial perfusion defect. 
 
Picture depicting the 16 segmental model for wall motion scoring 
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Echocardiography is helpful in the evaluation of chest pain, especially 
during active chest pain. The absence of LV wall motion abnormalities during 
chest pain usually but not always excludes myocardial ischemia or infarction, 
and the presence of regional wall motion abnormalities has a high sensitivity for 
detection of myocardial ischemia or infarction, although it is not specific. 
Myocardial contrast perfusion imaging provides incremental diagnostic value 
for patients with chest pain, with excellent concordance with gated SPECT 
(77% to 84%).
[17]
 However, routine use of echocardiography in this setting 
requires availability of appropriately trained personnel to perform 
echocardiography and to interpret its findings. 
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Wall motion analysis can also be performed more objectively and 
conveniently by speckle tracking strain imaging. Moreover, Ishii and 
colleagues
[18]
 elegantly demonstrated that diastolic relaxation of the ischemic 
myocardial segment remains abnormal long after resolution of the regional wall 
motion abnormality, and the diastolic relaxation abnormality can be detected by 
strain imaging. 
Assessment of Diastolic Function  
Thorough evaluation of diastolic function is essential, while assessing the 
cardiac function of a patient because about half of patients with heart failure 
have preserved LVEF. Echocardiography has become the preferred non-
invasive method to evaluate diastolic function and to estimate left ventricular 
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filling pressures. M-mode, two-dimensional, and Doppler (blood flow, tissue, 
and colour) echocardiography are all helpful in evaluating diastolic function. 
Recently, the American Society of Echocardiography (ASE) and the European 
Association of Echocardiography (EAE) published a guideline for assessment 
of diastolic function by echocardiography.
[19]
 The following steps will ensure 
comprehensive assessment of diastolic function and the identification of heart 
failure related to diastolic dysfunction: 
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LV diastolic filling consists of a series of events that are affected by numerous 
factors, including myocardial relaxation, compliance, cardiac rhythm, and 
pericardial compliance. Normal diastolic function ensures adequate filling of the 
ventricles during rest and exercise without an abnormal increase in diastolic 
pressure or pulmonary venous congestion. The initial diastolic event is 
myocardial relaxation,
[20]
 An active energy-dependent process that causes LV 
pressure to decrease rapidly after the end of contraction. When LV pressure 
falls below LA pressure, the mitral valve opens, and rapid early diastolic filling 
begins. Under normal circumstances, a major determinant of the driving force 
of early diastolic filling is the elastic recoil caused by normal relaxation of the 
left ventricle. Normally, 75% to 80% of LV filling occurs during this phase. 
During early diastolic filling, LV pressure continues to decrease until 
completion of myocardial relaxation (normally about 100 milliseconds) before 
rising after reaching minimal pressure; this loss of positive driving force results 
in the deceleration of mitral inflow. Later, atrial contraction produces a positive 
transmitral pressure gradient and inflow, accounting for 20% to 25% of LV 
filling in normal subjects. The proportion of LV filling during the early and late 
diastolic phases depends on elastic recoil (suction), rate of myocardial 
relaxation, chamber compliance, LA pressure, and heart rate. The LV filling 
pattern is the result of the transmitral pressure gradient produced by these 
various factors. 
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The transmitral pressure gradient or the relationship between LA and LV 
pressures is accurately reflected by mitral inflow Doppler velocities.
[20]
 
Diastolic filling is usually classified initially on the basis of the peak mitral flow 
velocity of the early rapid filling wave (E), peak velocity of the late filling wave 
caused by atrial contraction (A), E/A ratio, and deceleration time (DT), which is 
the time interval for the peak E velocity to reach zero baseline. 
With myocardial relaxation, the LV cavity elongates, expands laterally, and 
rotates. The longitudinal motion of the mitral annulus has been shown to 
correlate with the rate of myocardial relaxation. The velocity of the mitral 
annulus can be recorded by TDI, which has become an essential part of 
evaluation of diastolic function by echocardiography.
[21]
 Radial and 
circumferential function can also be assessed with speckle tracking strain 
imaging.
[22]
 
Comprehensive assessment of diastolic filling and estimation of filling 
pressures by echocardiography require Tissue Doppler Imaging (TDI), 
pulmonary vein Doppler, hepatic vein Doppler, and colour M-mode of mitral 
inflow for propagation velocity—sometimes with an alteration in a loading 
condition. The Valsalva maneuver is used most frequently to decrease venous 
return by increasing intrathoracic pressure.
[23]
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Grading of Diastolic Dysfunction (or Diastolic Filling Pattern)  
The grading of the diastolic filling pattern (or diastolic dysfunction) is 
based on several parameters.
[24]
 In most (if not all) cardiac diseases, the initial 
diastolic abnormality is impaired relaxation. With further progression of disease 
and a mild to moderate increase in LA pressure, the mitral inflow velocity 
pattern appears similar to a normal filling pattern (pseudonormalized). With 
further decrease in LV compliance and increase in LA pressure, diastolic filling 
becomes restrictive. Most patients with restrictive filling are symptomatic and 
have a poor prognosis unless the restrictive filling can be reversed by treatment. 
However, restrictive filling may be irreversible and represent the end stage of 
diastolic heart failure. Therefore, diastolic dysfunction can be graded according 
to the diastolic filling pattern.
[19]
  
 Grade 1 (mild dysfunction) - impaired relaxation with normal filling 
pressure 
 Grade 2 (moderate dysfunction) - pseudonormalized mitral inflow pattern 
 Grade 3 (severe reversible dysfunction) - reversible restrictive (high 
filling pressure) 
 Grade 4 (severe irreversible dysfunction) - irreversible restrictive (high 
filling pressure) 
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Grading of diastolic dysfunction by echocardiography
[38] 
 
A grade 1 diastolic filling pattern usually implies a normal filling pressure 
despite a background of impaired myocardial relaxation. However, in patients 
with a marked relaxation abnormality, as in Hypertrophic Cardiomyopathy, the 
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filling pressure can still be elevated with grade 1 mitral inflow velocity pattern 
(E/A ratio <1.0 and DT >240 milliseconds). Because the reversibility of 
restrictive filling usually cannot be assessed at one clinical setting, grade 4 
dysfunction was not used in the standard recommendations.
[19]
 
 
Clinical Applications of Diastolic Function Assessment  
Assessment of diastolic function echocardiographically has the following 
clinical applications and should be an integral part of an echocardiography 
examination.  
1. Estimation of filling pressures at rest and with exercise:-  
In patients with reduced LV systolic function (LVEF <35%), mitral 
inflow E/A ratio of 1.5 or higher and DT of 140 milliseconds or higher indicate 
increased filling pressures. However, these parameters do not have a good 
correlation with filling pressure in patients with normal LVEF and diastolic 
heart failure. For all degrees of LVEF, E/e′ is the best parameter to estimate 
filling pressure; pulmonary capillary wedge pressure (PCWP) is 20 mm Hg or 
more if E/e′ is 15 or higher, and PCWP is normal if E/e′ is less than 8.[19] When 
E/e′ is 8 or higher but less than 15, pulmonary vein flow duration and the 
Valsalva maneuver can help estimate PCWP. In an important subset of patients 
with diastolic dysfunction, PCWP is normal at rest but increases only with 
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exertion, causing exertional dyspnea. It is feasible and reliable to estimate 
PCWP with exercise by recording mitral inflow and annulus velocity. In a 
normal population with normal diastolic function, filling pressure rarely 
increases with exercise. Diastolic dysfunction (or impaired myocardial 
relaxation) is usually a prerequisite for development of exercise-induced high 
filling pressure. These patients increase cardiac output at the expense of 
increased filling pressure. In this situation, mitral E velocity increases while 
annulus Ea velocity does not increase as much or at all, resulting in an increase 
in E/e′ ratio. E/e′ correlates well with simultaneously measured PCWP with 
exercise as well as during resting stage, and a ratio higher than 15 indicates 
PCWP greater than 20 mm Hg with exercise.
[25] 
 
2. Diagnosis of cardiomyopathies, and constrictive pericarditis:-  
Knowledge of the diastolic filling pattern and filling pressures allows the 
detection of cardiac diseases that are frequently missed or not suspected 
clinically, especially when the LVEF is normal. Patients with diastolic heart 
failure and normal LVEF have a large LA volume and evidence of impaired 
relaxation as well as increased filling pressure. There are several reports that 
TDI of myocardial relaxation can diagnose various forms of cardiomyopathy 
(HCM, Fabry disease, and amyloidosis) even before frank phenotypic 
manifestation.
[26]
 The detection of constrictive pericarditis has been made much 
easier with the use of echocardiographic diastolic parameters and TDI.
[27] 
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3. Prognosis:-  
Diastolic echocardiographic parameters, E, E/A, DT, E/e′, and LA 
volume, have been found to be powerful prognostic indicators for various 
conditions.
[28,29]
 Even in asymptomatic patients, the presence of diastolic 
dysfunction portends a poor clinical outcome. 
Although diastolic filling is affected by various factors, the direction of 
its change or progression is predictable in patients with known heart disease. 
Therefore, assessment of the diastolic filling pattern allows LV filling pressures 
and LV compliance and relaxation to be estimated and understood so that 
optimal treatment strategies can be offered to symptomatic patients with 
diastolic dysfunction. 
Evaluation of Cardiac Function by Cardiac Time Intervals  
Cardiac time intervals are valuable tools which gives us a clear insight 
into systolic and diastolic function of the heart. Initially the Isovolumic 
contraction time (IVCT) duration and the preejection period (PEP) were 
analysed extensively as a measure of cardiac systolic function. The LV Stroke 
Volume was derived from the left ventricular ejection time. Myocardial 
dysfunction prolongs PEP and shortens LVET. However these intervals are also 
influenced by many other hemodynamic and electrical variables other than 
systolic dysfunction. An index called systolic time interval (PEP/LVET) was 
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derived by Weissler and colleagues, which was less heart rate dependent as a 
measure of LV systolic function. Because LV dysfunction also affects IVRT is 
also affected, Mancini and colleagues incorporated IVRT into an index called 
the isovolumic index, derived as (IVCT + IVRT)/LVET. The sum of IVCT and 
IVRT was measured by subtracting LVET from the peak of the R wave on the 
electrocardiogram to the onset of mitral valve opening. The isovolumic index 
was considered more sensitive for cardiac dysfunction than the systolic time 
interval because it contains IVRT as well as IVCT. However, the interval from 
the R wave peak to the onset of mitral valve opening contains an interval of 
electromechanical delay, which can be pronounced in patients with left bundle 
branch block. With the advent of Doppler echocardiography, it has become 
easier to determine cardiac time intervals more reliably. Tei and colleagues 
proposed an index of myocardial performance with Doppler echocardiography 
(IMP or Tei index) that is independent of the electromechanical delay, (IVCT + 
IVRT)/LVET, and can be used to identify the exact onset of isovolumic 
contraction.
[29]
 
The time intervals necessary for calculation of IMP are easily obtained 
with Doppler echocardiography and TDI
[30]
 as well as with M-mode 
echocardiography.
[31]
 The normal value is 0.39 ± 0.05, and its mean value is 
0.59 ± 0.10 in those with dilated cardiomyopathy. The IMP was evaluated for 
the right ventricle, especially in patients with pulmonary hypertension. When 
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myocardial relaxation is normal, the opening of the mitral valve is initiated by 
rapid suction of the left ventricle; hence, the onset of mitral valve opening is 
close to the onset of early diastolic movement (or velocity) of the mitral 
annulus.
[32]
 However, if myocardial relaxation is delayed, the mitral valve opens 
by high LA pressure. Therefore, the onset of diastolic motion of the mitral 
annulus follows the onset of mitral inflow. The time interval has been correlated 
with the degree of impairment in myocardial relaxation and LV filling pressure. 
With worsening of diastolic function, the time interval lengthens. 
Echocardiographic indices to assess the prognosis following Acute 
Myocardial Infarction 
Doppler echocardiographic assessment of hemodynamics in the acute 
setting of AMI provides independent, rapid, feasible, and simple non-invasive 
method of assessing the prognostic factors. This is particularly true in the 
subgroup of patients who have evidence of elevated LV filling pressures despite 
relatively preserved systolic function. 
 The most important prognostic indicators after Myocardial Infarction are 
the degree of LV systolic dysfunction, left ventricular end-systolic volume 
index, ejection fraction, infarct size as peak cardiac enzyme release, infarct 
location and transmurality, LV volume, LV sphericity, Mitral Regurgitation, 
diastolic function, frequent ventricular arrhythmias and presence of heart 
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failure.
[33,34,35]
 Therefore, it is reasonable to predict that patients with a high 
WMSI have a greater chance for subsequent development of cardiac events. 
Most patients with Killip class II-IV heart failure after acute Myocardial 
Infarction have a WMSI of 1.7 or higher. In addition to the WMSI, restrictive 
Doppler filling variables derived from mitral inflow velocities correlate well 
with the incidence of postinfarction heart failure and LV filling pressures.
[36,37]
 
The E/e′ ratio, a reliable parameter to estimate PCWP, was found to be a strong 
predictor for long-term outcome after acute Myocardial Infarction.
[36]
 LA 
volume, a surrogate for chronic diastolic dysfunction and chronic elevation of 
LA pressure, was also a strong predictor of outcome.
[38]
 Stress 
echocardiography is sensitive in detecting residual ischemia, myocardial 
viability, and multivessel disease soon after Myocardial Infarction
[39]
. Often, 
however, patients are unable to exercise adequately soon after an acute 
Myocardial Infarction, and the myocardium may remain akinetic for a period of 
days to weeks after successful reperfusion of the occluded coronary artery. 
Demonstration of viability by augmentation of contractility (with dobutamine 
echocardiography) or demonstration of perfusion (with contrast 
echocardiography) predicts functional recovery 
In a meta-analysis of 12 prospective clinical trials, of survivors of acute 
myocardial infarction, Whalley et al
[44]
 studied whether simple, universally 
available Doppler echocardiographic measurements of left ventricular diastolic 
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function predict clinical outcome. The final analysis provided important 
findings. Despite the lack of data on the impact of the precise timing of the 
Doppler echocardiogram, the different baseline demographics, and the potential 
influence of discordant postinfarction pharmacotherapies between the 2 groups, 
two clear conclusions can be drawn. The first conclusion is that a restrictive left 
ventricular filling pattern, even in the presence of a normal ejection fraction, 
predicts clinical outcome after infarction. There is a 3-fold increase in risk of 
death when Restrictive filling is present. A restrictive filling pattern provides 
incremental prognostic information over and above that of left ventricular 
volumes and Killip class. The second conclusion that can be drawn is for 
stratification of patients at increased risk following myocardial infarction, left 
ventricular filling profiles should be evaluated. 
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MATERIALS AND METHODS 
Individuals who were admitted for acute Myocardial Infarction in the 
Intensive Coronary Care Unit, Department of Cardiology, Govt. Stanley 
Hospital from April 2011 to September 2011 were evaluated in this study. Their 
Left Ventricular Systolic and Diastolic function was assessed by 2D Doppler 
Echocardiography within 48 hours of admission.  
Left Ventricular Ejection Fraction – the most well accepted expression of 
systolic Left Ventricular function is measured with the help of 2D 
echocardiography. 
Regional Wall Motion Abnormalities are also assessed and graded as: 
1 Normal  
2 Hypokinesia 
3 Severe Hypokinesia -akinesia 
4 Dyskinesia 
5 Aneurysm  
On the basis of this wall motion analysis scheme, a wall motion score 
index (WMSI) is calculated to semiquantitate the extent of regional wall motion 
abnormalities: 
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A normal left ventricle has a WMSI of 1, and the index increases as wall 
motion abnormalities become more severe. For purposes of regional wall 
motion analysis, the ASE has recommended a 16-segment model. Segments are 
visualised from the parasternal, apical, and subcostal imaging windows. The 
segments are labelled at three levels – Apical, mid-papillary, Basal. The levels 
are depicted below: 
Table showing segmental levels for RWMI scoring 
Segment level Basal Mid-papillary Apical 
Antroseptal 1 7 13 
Anterior 2 8 14 
Anterolateral 3 9 15 
Posterolateral 4 10 - 
Inferior 5 11 16 
Inferoseptal 6 12 13 
 
Diastolic function is assessed by measuring the Trans-Mitral pressure 
gradients using Doppler Echocardiography. 
Diastolic dysfunction is graded according to the filling pattern into: 
Grade I – impaired relaxation with normal filling pressures 
Grade II – Pseudonormalised mitral inflow pattern 
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Grade III – reversible restrictive pattern 
Grade IV – irreversible restrictive pattern 
The systolic and diastolic dysfunction assessed by the above methods is 
correlated with other variables such as Age, Sex, Smoking, Type of Myocardial 
Infarction, Killip class. 
Killip Classification: 
 Class I – no signs of heart failure,  
 Class II – crackles in lower lung fields and S3,  
 Class III – acute pulmonary edema,  
 Class IV – cardiogenic shock). 
 The patients were clinically monitored for the development of early in-
hospital congestive cardiac failure during the period of admission. Patients with 
Killip class ≥ II were defined as having heart failure. The Killip class is assessed 
every day and the highest class is taken for consideration. According to Killip 
classification, the patients were divided into two groups: those without CHF 
(Killip class = I) and those with CHF (Killip class ≥ II). Other adverse events 
during in-hospital evolution that could also be related to other factors and not 
related to LV dysfunction alone, like recurrent angina or early malignant 
arrhythmias due to electrical instability that could lead to different results were 
not considered. 
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Patients were observed during daily in-hospital evolution, after receiving 
conventional clinical therapy (with betablockers and angiotensin converting 
enzyme inhibitors). All patients received reperfusion therapy by streptokinase as 
per standard guidelines. 
 
INCLUSION CRITERIA 
- Patients of both sex, aged between 30 and 60 with Acute Myocardial 
Infarction (STEMI) who are admitted in the Intensive Coronary Care Unit. 
- Patients undergoing thrombolysis using streptokinase. 
 
EXCLUSION CRITERIA 
- Patients with Non ST elevation myocardial infarction.  
- Patients who have contraindications for thrombolysis. 
- Patients with previous history of myocardial infarction. 
- Patients with complete heart block. 
- Patients with atrial fibrillation. 
- Patients with other co-morbidities such as Chronic Kidney disease, Chronic 
Obstructive Pulmonary Disease. 
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- Patients with prior history of heart failure symptoms. 
- Patients with valvular heart disease. 
- Patients with cardiomyopathies. 
Statistical analysis 
 Data were represented as mean ± SD or percentage of the total, unless 
otherwise specified. Statistical analysis was done using SPSS ver. 20. 
Comparison between continuous variables was done using Mann Whitney U 
test or ANOVA. ROC curves were plotted to determine the ideal cutoff for 
Echocardiographic variables for predicting heart failure. Univariate logistic 
regression was used to compare the clinical and echocardiographic variables 
with heart failure. The significant variables in univariate analysis were added to 
a complete model of multivariate logistic regression. P value of <0.05 was 
considered significant. 
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OBSERVATIONS AND DATA ANALYSIS 
 
 All the 50 patients included in the study presented with isolated acute ST 
elevation Myocardial Infarction. All the patients had regional wall motion 
abnormalities in their Echocardiogram and underwent thrombolysis. The study 
group included 36 males and 14 females. The difference in sex wise distribution 
is obvious, as only patients between the age of 30 and 60 were included in the 
study and in this age group STEMI is more common in males.  
 The age wise distribution chart shows that the incidence of STEMI 
increases as the age advances.  It is also seen that the maximum number of 
female patients are in the 56-60 group, implying that the risk for MI increases 
during the post menopausal period. 
 
 
 
 
Table 1 - AGE GROUP and SEX wise distribution 
 SEX Total 
Female Male 
AGE GROUP <40 1 3 4 
41-45 2 4 6 
46-50 3 8 11 
51-55 2 11 13 
56-60 6 10 16 
Total 14 36 50 
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 Table 2 compares the MI location with age, sex and admission blood 
pressure. There was no significant difference in age or sex wise distribution 
between the two groups mean age in the Anterior MI group was 51 years 
compared to a mean age of 52 in the Inferior MI group. Males had higher 
incidence of Anterior MI compared to females in whom the incidence of 
anterior and inferior was same. However the difference was not statistically 
significant when compare with a fisher exact test (p=0.325
f
). The mean systolic 
blood pressure was higher in the Anterior MI group (133 ± 26 vs 117 ± 30) 
however the difference did not reach statistical significance (p>0.05). The 
diastolic blood pressure was not much different (83mmHgcompared with 
89mmHg) in both the groups (p>0.05).  
 
Table 2 - Distribution based on type of MI 
MI type 
AGE SEX SBP DBP 
Mean ± SD 
Female Male 
Mean ± SD Mean ± SD 
Count Count 
Inferior 52 ± 7 7 11 117 ± 30 83 ± 20 
Anterior 51 ± 6 7 25 133 ± 26 89 ± 19 
p ( ANOVA) 0.426 0.325
f 
0.057 0.303 
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Table 3 – Echocardiographic parameters in MI types 
 
Type of Myocardial infarction 
Inferior Anterior 
Comparison between 
groups (ANOVA) 
Mean ± SD Mean ± SD F p 
LVEF 48 ± 13 42 ± 10 4.281 0.044* 
LVEDD 4.5833 ± 0.8847 4.7750 ± 0.8116 0.602 0.441 
LVESD 3.4278 ± 0.9067 3.7781 ± 0.8003 2.006 0.163 
RWMI 1.3056 ± .0770 1.5742  ± 0.3309 11.421 0.001* 
 
 
 Table 3 shows the various Echocardiographic parameters and their 
distribution among the MI types. The mean LVEF (Left Ventricular Ejection 
Fraction) is lower in the Anterior MI group (p<0.05) implying that Anterior 
Myocardial Infarction patients are more likely to develop LV systolic 
dysfunction, which is not surprising given the fact that Anterior MI tends to 
affect larger area of left ventricle. Both left ventricular end systolic and end 
diastolic diameters were higher in Anterior MI patents, but the difference was 
not statistically significant (p>0.05). The regional wall motion scoring index 
(RWMI) was higher in Anterior MI patients (1.57 ± 0.33 vs 1.30 ± 0.07). This 
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was statistically significant (p<0.05) and can be explained by the difference in 
infarct dimensions among the groups. 
 
Table 4 – Diastolic dysfunction in MI types 
Grading of diastolic 
dysfunction 
MI type 
Inferior Anterior Total 
Normal  8 18 26 
Grade 1 8 12 20 
Grade 2 2 2 4 
Grade 3 - - - 
Grade 4 - - - 
p (fisher’s exact)  0.606 
 
 
Table 4 shows the distribution of diastolic dysfunction between the MI 
groups. There was no significant difference in the distribution of diastolic 
dysfunction among the MI types (p>0.05). Diastolic dysfunction tends to be 
equally distributed between anterior and inferior myocardial infarction groups. 
26 patients (52%) had normal LV filling, and 24 patients (48%) had diastolic 
dysfunction. Among them 20 had grade I diastolic dysfunction and only 4 had 
grade II diastolic dysfunction. None had grade III or grade IV diastolic 
dysfunction which is uncommon in the setting of first AMI. 
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Table 5 – Systolic and Diastolic dysfunction in MI types 
MI  type 
LVEF RWMI DD 
≤40% >40% <1.7 ≥1.7 Absent Present 
Inferior 5 13 18 0 8 10 
Anterior 20 12 21 11 18 14 
p (fisher’s exact) 0.038* 0.004* 0.557 
 
 
 
Table 6 – Systolic and Diastolic dysfunction in males and females 
Sex 
LVEF RWMI DD 
≤40% >40% <1.7 ≥1.7 Absent Present 
Female 4 10 12 2 10 4 
Male 21 15 27 9 16 20 
p (fisher’s exact) 0.114 0.481 0.119 
 
 
Table 5 shows the distribution of abnormal echocardiographic indices of 
systolic and diastolic dysfunction, between the MI types. The left ventricular 
Ejection Fraction was significantly less in the anterior MI group compared to 
the inferior MI group (p<0.05). Similarly the regional wall motion scoring index 
also was higher in the anterior MI group (p<0.05). However Diastolic 
dysfunction was equally distributed between the MI types. 
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Table 6 shows the sex wise distribution of echocardiographic indices. 
There was no significant difference between the sexes. 
 
Table 7 – Systolic and Diastolic dysfunction in different age groups 
Age group 
LVEF RWMI DD 
≤40% >40% <1.7 ≥1.7 Absent Present 
<40 0 4 4 0 3 1 
41-45 3 3 3 3 2 4 
46-50 9 2 10 1 5 6 
51-55 7 6 8 5 6 7 
56-60 6 10 14 2 10 6 
p (fisher’s exact) 0.046* 0.116 0.619 
 
In table 7, apart from asymmetric distribution of depressed left 
ventricular ejection fraction among different age groups, the other parameters -  
RWMI and DD were equally distributed.  
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Table 8 – Hospital stay for different groups (in days) 
Clinical variable  
ICCU TOTAL HOSP STAY 
Mean 
Standard 
Deviation 
Mean 
Standard 
Deviation 
SEX 
Female 2.545 0.688 6.636 0.674 
Male 2.676 0.768 6.912 0.996 
MI 
type 
Inferior 2.750 0.856 7.000 1.155 
Anterior 2.586 0.682 6.759 0.786 
DM 
No 2.703 0.740 6.892 0.966 
Yes 2.375 0.744 6.625 0.744 
SM 
No 2.500 0.673 6.545 0.671 
Yes 2.783 0.795 7.130 1.058 
HF 
No 2.368 0.496 6.684 0.671 
Yes 2.846 0.834 6.962 1.076 
 
Table 8 shows the duration of hospitalisation of patients. There was no 
difference in number of days of ICCU stay or hospital stay between males and 
females. Diabetics had higher duration of ICCU and hospital stay compared 
with non-diabetics. Similarly smokers also had a higher duration of 
hospitalisation. Patients with symptoms of heart failure had longer duration of 
ICCU as well as total hospital stay as expected. 
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Analysis of early in hospital congestive heart failure in AMI patients: 
 All the 50 patients were monitored for development of early in-hospital 
congestive heart failure (defined as Killip class ≥ II). The highest class during 
the hospital stay was considered for analysis. 
   
 
Table 9 – Heart failure in different MI types 
MI type 
Heart Failure (Killip class ≥ II) 
Absent Present 
Inferior 9 9 
Anterior 10 22 
p (fisher’s 
exact) 
0.233 
 
 
There was no significant difference in incidence of heart failure among 
the different MI types (p>0.05). Table 9 depicts the figures.  
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Table 10 – Heart failure in different age groups 
Sex 
Heart Failure (Killip class ≥ II) 
Absent Present 
<40 3 1 
41-45 3 3 
46-50 4 7 
51-55 3 10 
56-60 6 10 
p (fisher’s 
exact) 
0.425 
 
Table 10 shows the incidence of heart failure following AMI in different 
age groups. Older patients had higher percentage of heart failure symptoms. 
However the difference in heart failure rates among the age groups, did not 
reach statistical significance (p>0.05). 
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Table 11 – Heart failure in different sex groups 
Sex 
Heart Failure (Killip class ≥ II) 
Absent Present 
Male  11 25 
Female 8 6 
p (fisher’s 
exact) 
0.110 
 
Table 11 shows the sex wise difference in development of heart failure. 
Though the number of males developing heart failure was higher the difference 
was not statistically significant (p>0.05). 
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Table 12 – Baseline Clinical variables in Heart failure groups 
Clinical variables 
Heart Failure (Killip class ≥ II) 
P value 
 
Absent (n=19) Present (n=31) 
Age (years) 50.16 ± 6.98 52.29 ± 5.23 0.336 
Systemic Hypertension  6 (50%) 6 (50%) 0.496 
Admission SBP 136.32 ± 29.10 121.55 ± 26.38 0.143 
Admission DBP 90.53 ± 16.82 83.87 ± 20.11 0.347 
Diabetes Mellitus 1 (8.3%) 11 (91.7%) 0.018* 
Smoking 6 (24%) 19 (74%) 0.079 
Hyperlipidemia 4 (33.3%) 8 (66.7%) 0.490 
No. of days in ICCU 2.37 ±  0.50 2.85 ± 0.83 0.046* 
Total no. of days in hospital 6.68 ±  0.67 6.96 ± 1.08 0.514 
 
  
The baseline clinical parameters are compared between the heart failure 
groups in table 12. The mean age of patient with heart failure was 52.29 years 
compared to 50.16 years for the normal group. This difference was not 
significant (p>0.05). Prior history of systemic hypertension was comparable 
between the groups. The admission mean systolic blood pressure was 15 mmHg 
lower (121.55 vs 136.32) in the heart failure group. This difference can be 
attributed to the patients with cardiogenic shock in the heart failure group. The 
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difference was not statistically significant (p>0.05). The mean diastolic blood 
pressure was also marginally higher (90.53 vs 83.87) in the normal group. 
 
 
Table 13 – Echocardiographic variables in heart Failure groups 
Echocardiographic  
Variables 
No Heart Failure 
(n=19) 
Heart Failure 
(n=31) 
P value 
(Mann-  
Whitney) 
Mean SD Mean SD 
LVEDD 4.28 0.72 4.96 0.80 0.003* 
LVESD 3.10 0.69 3.99 0.76 <.001* 
LVEF 52.53 9.61 38.81 8.53 <.001* 
RWMI 1.38 0.25 1.53 0.31 0.038* 
 
  
Table 13 depicts the various echocardiographic parameters in the two 
groups. The mean Left ventricular end diastolic diameter was higher in the heart 
failure group with mean 4.96 ± 0.8 cm compared to the patients without heart 
failure who had a mean of 4.28 ± 0.72 cm. The difference was statistically 
significant when compared using the Mann Whitney u test (p<0.05). 
 Similarly the LV End Systolic diameter was higher in the heart failure 
group mean 3.99 ± 0.76 cm compared to normal group mean of 3.10 ± 0.69 cm. 
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Again the difference was statistically significant with a p <0.05. LV Ejection 
Fraction the main parameter for assessing systolic function was lower in the 
heart failure group 38.81 ± 8.53 vs 52.53 ± 9.61. The difference was highly 
significant statistically (p <0.001). The regional wall motion scoring index also 
was higher in the heart failure group as expected. The mean in the heart failure 
group was 1.53 ± 31 compared with the mean of 1.38 ± 0.25 in the normal 
group. The difference was statistically significant (p<0.05). From this table we 
can conclude that the echocardiographic parameters are significantly abnormal 
in the heart failure group compared with the normal group. Among the 
echocardiographic parameters the LV ejection fraction had the most significant 
difference between the groups.  
 
Table 14 – Diastolic dysfunction in Heart failure groups 
Grading of diastolic 
dysfunction 
Heart failure 
Absent  Present Total 
Normal  15 11 26 
Grade 1 3 17 20 
Grade 2 1 3 4 
Grade 3 - - - 
Grade 4 - - - 
p  0.008* 
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Table 14 shows the distribution of diastolic dysfunction between the 
normal and heart failure groups. 24 out of 50 patients (48%) had diastolic 
dysfunction as assessed by Doppler Echocardiography. 20 patients with heart 
failure had diastolic dysfunction, whereas only 4 without heart failure 
symptoms had diastolic dysfunction by echocardiography. This difference was 
statistically significant (with p<0.05). Out of the 24 patients with Diastolic 
dysfunction 20 had Grade I diastolic dysfunction and 4 had Grade II diastolic 
dysfunction. Among the 4 patients with Grade II diastolic dysfunction 3 had 
signs of heart failure. Hence it appears that diastolic dysfunction as detected by 
echocardiography has a significant relationship with heart failure. 
 
 
 
 
Table 15 – ROC curves for LVEF and RWMI 
Variable 
Area under curve 
(AUC) 
Standard 
error 
95% confidence 
interval 
p 
LVEF 0.862 0.0539 0.735 to 0.943 <0.0001* 
RWMI 0.671 0.0750 0.523 to 0.797 0.0229* 
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Table 16 – Cut off values based on ROC curves for LVEF and RWMI 
Variable Sensitivity  Specificity PPV NPV 
LVEF ≤ 40 74.2 89.5 92.0 68.0 
RWMI ≥ 1.7 20.5 94.7 86.3 42.2 
 
 
 Table 15 shows the ROC (Receiver Operating Characteristics) curve 
parameters. The ROC curve was plotted to assess the predictive (diagnostic 
ability of the Echocardiographic parameters in detecting heart failure).  
LV Ejection Fraction had an AUC (area under the curve) of 0.862 which 
denotes that the LVEF has very high diagnostic accuracy in predicting heart 
failure (p value of <0.0001). 
 Wall motion scoring index had an AUC of 0.671 with a p value of <0.05 
also had good ability to detect heart failure but not to the extent of LV Ejection 
Fraction.  
In table 16, based on the ROC curves cut offs were estabilished which 
helps to  classify patients accutately. LVEF ≤ 40 had the best predictive ability. 
Similarly RWMI >1.7 though did not have the highest predictive ability was 
chosen since it had very good specificity of 90%.  
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Table 17 – Univariate Regression analysis for determining variables 
associated with early Heart Failure 
Variable Odds ratio 
Regression 
coefficient 
Standard 
error 
P 
Age 1.063 0.061 0.050 0.222 
Sex 3.030 1.109 0.650 0.088 
MI type 2.200 0.788 0.606 0.193 
SBP 0.980 -0.020 0.012 0.084 
DM 9.900 2.293 1.094 0.036* 
SM 3.431 1.233 0.616 0.045* 
LVEF ≤ 40 24.437 3.196 0.853 <0.001* 
RWMI ≤ 1.7 8.571 2.148 1.097 0.049* 
DD 6.818 1.920 0.676 0.005* 
 
 
 Table – 17 shows the univariate regression analysis correlating all the 
clinical and echocardiographic variables with heart failure. There was no 
significant correlation between clinical parameters age, sex, MI location, 
admission Systolic blood pressure. Diabetes was significantly correlating with 
heart failure. Diabetic patients were 9 times more likely to develop heart failure 
symptoms following AMI compared with non-diabetics (p value of <0.05). 
Similarly smokers were also 3 times more likely to develop heart failure 
compared to non-smokers (p value of <0.05) 
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Among the Echocardiographic parameters LV Ejection Fraction <40 had 
the strongest predicting ability with an odds ratio of 24 which was statistically 
highly significant (p<0.001). Wall motion scoring index and diastolic 
dysfunction also had good ability to predict heart failure with an odds ratio of 9 
and 7 respectively (p value <0.05). 
 
 
Table 18 – Multivariate Logistic regression 
Variable Odds ratio Regression Coefficient Standard error p 
LVEF ≤ 40 14.386 2.666 0.915 0.004* 
DD 5.738 1.747 0.829 0.035* 
RWMI ≥ 1.7 4.862 1.581 1.514 0.218 
Constant 0.212 -1.552 0.608 0.011* 
 
 
  
Table 18 shows the Multivariate regression model where all the three 
significantly correlating echocardiographic parameters (in univariate analysis) 
are simultaneously analysed for any confounders and interdependence among 
the variables. The overall model was statistically significant with a p value of 
<0.001. LV Ejection Fraction and Diastolic Dysfunction correlated significantly 
with heart failure. The corrected odds ratio for LVEF ≤ 40 for predicting heart 
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failure was 14.38 ie a patient with a LVEF of less than 40% is 14 times more 
likely to develop heart failure symptoms than a patient with LVEF >40. The 
corrected odds ratio for Diastolic Dysfunction was 5.74, and it was statistically 
significant with a p value of 0.035.   
However the Regional Wall Motion Scoring Index though had a higher 
odds associating it with heart failure, it was not statistically significant within 
the model. This paradox is likely due to the fact that LV ejection fraction and 
Wall Motion Scoring are highly inter-dependent variables. When both of them 
are included in the model it becomes superfluous. Further when we look at the 
univariate analysis the correlation between LV Ejection Fraction and heart 
failure is better than that between Regional Wall Motion Scoring Index and 
heart failure. This could be because of the complex and operator dependent 
nature of the index. 
All the clinical and echocardiographic variables couldn’t be analysed in 
the same Multivariate Logistic Regression model, making it less robust as the 
sample size was small and the number of variables to sample ratio should be 
maintained more than at least 1:10 or preferably 1:20. So only the three main 
echocardiographic variables were included in the regression model. 
 When backward conditional elimination of variables was followed, Wall 
motion scoring index was removed from the model and only LV Ejection 
Fraction and Diastolic Dysfunction remained. On the whole the model was able 
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to accurately classify the patients into heart failure or normal in 80% of the 
cases.  
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DISCUSSION 
 Fifty patients with first Acute Myocardial Infarction were evaluated in the 
study. The study mainly focuses on the echocardiographic evaluation of patients 
with AMI and identification of left ventricular systolic and diastolic dysfunction 
in them. 
 In our study 50% (n=25) of the patients had systolic dysfunction (LV 
ejection fraction <40%). As patients with previous MI, heart failure symptoms 
or valvular heart disease have been excluded, the systolic dysfunction can be 
predominantly attributed to the index coronary event. In a similar Portuguese 
study by PS Mateus et al,
[41]
 56% had LV systolic dysfunction (they had used 
LEVF cut-off of 45%). The TRACE trial
[42]
 had a more stringent cut off 
(LVEF<35%) and found that 40% had Systolic dysfunction. In a Kosovo study 
by Kocinaj D et al
[43]
 48% of patients with first AMI had LV systolic 
dysfunction. Our study results were comparable with other similar studies with 
similar cut-off for detecting LV systolic dysfunction. 
 A total of 24 out of 50 patients (48%) had restrictive filling pattern in 
echocardiogram (diastolic dysfunction). In a similar study by S H Poulsen et 
al,
[45]
 35% of the patients had impaired LV filling pattern. However the range 
varied widely from 20% in a study by Whalley et al
[44] 
to 65% in a study by LP 
Souza et al.
[42] 
This wide variation among studies can be explained by the fact 
that different echocardiographic parameters and different criteria were used to 
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identify patients with diastolic dysfunction. Our study which graded diastolic 
dysfunction based on the ASE/EAE guidelines
[46]
 pegged the incidence of 
diastolic dysfunction at 48% following AMI, which was midway between the 
extreme ranges reported in other studies.  
 The age, sex wise distribution of systolic and diastolic dysfunction was 
not statistically significant. Systolic dysfunction was found more frequently in 
patients with Anterior MI compared with inferior MI. Many studies in the past 
had similar results comparing the site of infarction with LV ejection fraction. In 
the study by Mc Clements BM et al,
[47]  
the LV ejection fraction was 8% lower 
for anterior compared with inferior MI. 
 The Regional wall motion scoring index was significantly higher in the 
Anterior MI group. The same has been shown in other similar studies by 
McClements BM et al, 
[47]  
Souza et al.
[42] 
 
 The incidence of heart failure symptoms (as defined by Killip class ≥ II) 
was 63% (n=31). This was both at the time of hospital admission as well as 
during the subsequent stay in the hospital. In the Souza et al
[42] 
 study the 
incidence of heart failure was 44%. In the study of Yuasa
[51]
 et al which 
included CHF among other end points such as paroxysmal atrial fibrillation, 
ventricular tachycardia, ventricular fibrillation, AV block, pericardial effusion 
and cardiac rupture, the prevalence of  CHF was only 19%. The Valsartan in 
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Acute Myocardial Infarction trial (VALIANT) trial
[48]
 showed an incidence of 
23.1 at admission, with a higher number being discharged with a diuretic. 
 In our study only LVEF and presence of DD were strong independent 
predictors for the development of early CHF following AMI. In the Souza et 
al
[42] 
 study only LVEF (<45%) was a statistically significant echocardiographic 
index for predicting early CHF. Wall motion scoring index, when adjusted for 
age also was a good predictor. However in our study wall motion scoring index 
though correlated well in the univariate analysis did not reach statistical 
significance in the multivariate regression analysis. In the above study they also 
correlated Myocardial Performance Index (MPI) with heart failure. However 
even though MPI is a global myocardial performance index including both 
systolic and diastolic echocardiographic indices, it did not significantly correlate 
with development of heart failure symptoms. 
 Lavine
[49]
 in a retrospective study also found that LVEF was superior to 
other indices in predicting development of heart failure in patients without any 
clinical evidence of CHF at admission during the first 15 days of admission 
following AMI. In the study by schwammenthal et al.
[50]
 also reported a LVEF ≤ 
0.40 as a powerful and independent predictor of poor outcome 
 Regional wall motion scoring index of LV systolic function did not 
provide any additional prognostic information over LV ejection fraction. This 
paradox may be explained by the fact the both variables are interdependent and 
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Wall motion analysis is a complex and highly subjective quantification index 
with a high degree inter-observer variation. In comparison LVEF is an easily 
measurable echocardiographic index and is easily reproducible, thereby the 
errors in LVEF estimation are vey less. Similar findings were obtained in 
studies by Yuvasa et al 
[51]
 and DeMichele.
 [52]
 
 Similar to many other studies like Souza et al, Diabetes and Smoking 
were predictors of early in hospital heart failure in the univariate analysis. 
Further studies are needed with larger study population to assess the 
interdependence of clinical and echocardiographic parameters. 
 
Limitations of the study 
Though extremes of age were excluded in the study to minimise the 
influence of age on diastolic dysfunction, the study group included a sizeable 
number of diabetics and hypertensives who might have pre-existing diastolic 
dysfunction, which might confound the results. 
Our results about the prognostic influence of Regional Wall Motion 
scoring Index for first ST-elevation AMI was inconclusive, due to the limited 
number of patients in the study group and operator dependant nature of the 
index.  
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We couldn’t analyse all the clinical and echocardiographic variables 
simultaneously in the multivariate logistic regression as the study group was 
small and the variable to population ratio (1:10) would exceed the guidelines. 
The recent global indices of systolic and diastolic function like the MPI 
were not included for analysis. 
The individual diastolic parameters such as E/A ration, DT were not 
compared with heart failure. 
.  
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CONCLUSIONS 
 In this study population of 50 patients with first AMI and without 
previous heart failure symptoms, the incidence of early in-hospital 
congestive heart failure was 62% (n=31). 
 48% of the patients with first AMI had diastolic dysfunction. 
 50% of patients had systolic dysfunction (defined as ejection fraction of ≤ 
40%). 
 22% of patients had a Regional Wall Motion Scoring Index of ≥1.7. 
 Left ventricular ejection fraction was the most important predictor of 
early heart failure (p=0.004). 
 The cut off ≤ 40% of LVEF had a high predictive value (74% sensitivity 
90% specificity) in detecting patients who are likely to develop heart 
failure symptoms. 
 Presence of Diastolic dysfunction also predicted early heart failure 
following AMI accurately (p=0.035). 
 Regional Wall Motion Index was inferior compared to LVEF and 
presence of DD in predicting heart failure (p=0.218). 
 Smokers were more likely to develop early in-hospital heart failure 
following AMI (p=0.045). 
 Diabetes was one of the important risk factors for the development of 
heart failure following AMI (p=0.036). 
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PROFORMA 
 
S.no: 
Date: 
Name: 
Age: 
Sex: 
Address: 
 
Contact phone no: 
Occupation: 
 
Past history of Diabetes/ Hypertension: 
Family history of Coronary Artery Disease: 
Presenting complaints: 
  
Pulse:                                   BP:   
CVS:                                      RS: 
Killip Class: 
ECG (Type of Myocardial Infarction, Probable site of coronary occlusion): 
Routine investigations: 
 Random blood sugar: 
Serum Creatinine in mg/dl: 
Blood urea nitrogen in mg/dl: 
 ECHOCARDIOGRAPHY                      
 Left Ventricular Ejection Fraction: 
 Regional Wall motion index:  
Diastolic dysfunction grade: 
Clinical monitoring for Cardiac Failure during hospital stay 
 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
JVP        
S3, S4        
Basal Crackles        
Pedal Edema        
 
NO. NAME IP NO AGE SEX TYPE OF MI SBP DBP DM SHT SM HL KILLIP ICCU HOSP A/D LVEDD LVESD LVEF RWMI DD 
1 Noorulla 28378 39 M ASMI 110 70     1 2 6 A 4.1 2.9 50 1.3125  
2 Anthony 28504 58 M IPWMI/RVMI 120 70  + +  1 2 8 A 4.7 3.1 60 1.25  
3 Arunachalam 28778 57 M IPWMI/RVMI 160 100    + 1 3 6 A 5.6 4.2 48 1.25 1 
4 Durgammal 31303 59 F IPWMI/RVMI 82 56 +   + 4   D 5.8 4.9 29 1.375 1 
5 Periyanthevan 31772 42 M AWMI 150 90 +  +  2 2 8 A 6.6 5.3 38 1.75 1 
6 Rathinam 31787 50 M IWMI/RVMI 84 60   +  4 5 10 A 5.1 4.2 32 1.25  
7 Anthony 32621 54 M AWMI 140 100   +  1 3 7 A 3.4 2 68 1.25  
8 Rani 32954 50 F ALMI 200 110  +   1 3 6 A 4 3 48 1.375  
9 Sivaraj 33002 52 M AWMI 150 100 + +   1 4 6 A 5.1 4.2 35 1.375  
10 Parvathy 33062 45 F IPWMI 210 140  +   1 2 7 A 3.4 2.2 64 1.375  
11 Kasi 33159 52 M ASMI 130 90   + + 2 3 8 A 4.3 3.4 37 1.25  
12 Jayaraj 33215 43 M AWMI 120 100   +  1 4 8 A 5 4.2 33 1.875  
13 Sundar 33446 50 M IWMI/RVMI 96 64 +  +  3   D 5.1 4.3 32 1.25 2 
14 Dhanalakshmi 33617 52 F AWMI 130 80 + +   1 2 7 A 5.3 3.9 53 1.375  
15 Palani 33622 50 M ASMI 120 70     1 3 6 A 5 4 39 1.25  
16 Mohamed Hasen 33682 58 M IPWMI 110 70   +  1 3 7 A 4.7 2.9 69 1.25  
17 Kamalakannnan 33702 58 M ASMI 150 100   + + 1 3 6 A 4.8 3.6 48 1.5625  
18 Lakshmi 33773 59 F IPWMI 120 90    + 1 3 6 A 4.4 2.9 60 1.375  
19 Karpagam 33791 40 F IPWMI 100 70     1 3 6 A 5.1 3.7 52 1.375  
20 Rajammal 33960 45 F IWMI 120 100     1 3 7 A 4 2.8 58 1.25  
21 Munuswamy 34821 58 M ASMI 140 100    + 2 2 6 A 3.4 2.9 35 1.75  
22 Aruldas 34883 54 M AWMI 130 90 +  +  1 3 6 A 5 4 39 1.375 1 
23 Manoharan 35019 53 M IWMI 120 90   +  2 3 8 A 5.6 4.2 44 1.125 1 
24 Mohanlal 35167 46 M ASMI 130 90  +   1 2 6 A 4.7 3.9 35 1.25  
25 Thanikachalam 35342 59 M ASMI 120 90 +   + 2 2 7 A 5 4 40 1.5625  
SBP –Systolic blood pressure, DBP – Diastolic blood pressure, DM – Diabetes, SHT – Systemic hypertension, SM – Smoking, HL – Hyperlipidemia,  ICCU – No 
of days in ICCU, HOSP – total no of days in hospital, A/D – Alive/Dead, LVEDD Left Ventricular End Diastolic Dimension, LVESD – Left Ventricular End Systolic 
Dimension, LVEF – Left Ventricular Ejection Fraction, RWMI – Regional Wall Motion Scoring Index, DD – Diastolic Dysfunction (grading). 
NO. NAME IP NO AGE SEX TYPE OF MI SBP DBP DM SHT SM HL KILLIP ICCU HOSP A/D LVEDD LVESD LVEF RWMI DD 
26 Rajammal 35513 48 F ASMI 130 90 
 
+ 
  
3 4 7 A 6.5 5.2 38 1.5625 
 27 Krishnamorthy 35549 53 M IPWMI 100 80 
    
1 2 6 A 4 3.2 42 1.375 
 28 Rajammal 35718 59 F AWMI 130 90 
   
+ 1 2 6 A 3.8 2.4 66 1.25 
 29 Saraswathi 35746 57 F IWMI 140 100 
   
+ 1 2 8 A 3.2 2.1 60 1.25 
 30 Puspharaj  35821 51 M ASMI 140 100 
  
+ 
 
3 3 8 A 4.8 4 32 2.125 1 
31 Venkatesan 35881 40 M ALMI 130 80 
  
+ 
 
1 2 7 A 4.1 2.8 58 1.25 1 
32 Pasupathy 35916 52 M ASMI 140 100 
 
+ + 
 
2 2 6 A 5.5 4.8 28 1.75 
 33 Lakshmi 35922 50 F AWMI 130 90 
    
1 2 7 A 4 3.2 42 1.375 
 34 Arumugam 36054 38 M IPWMI/RVMI 110 80 
  
+ 
 
1 3 6 A 3.1 2.2 52 1.375 
 35 Dhanalakshmi 36949 58 F ASMI 82 40 + 
  
+ 4 
  
D 5.5 4.8 28 1.75 
 36 Eshvaran 37208 50 M AWMI 160 100 
 
+ 
  
1 2 7 A 5.6 4.6 38 1.375 
 37 Bharathi 37367 55 F ASMI 86 50 
 
+ 
  
4 
  
D 3.4 2.9 35 1.75 
 38 Anbalagan 37442 52 M AWMI 200 140 
 
+ 
  
2 3 8 A 4.2 3.2 44 2.125 2 
39 Salavudeen 37483 50 M IWMI 86 68 
 
+ + 
 
4 4 8 A 5.8 5 28 1.375 1 
40 Asaithambi 37520 58 M ASMI 88 60 
  
+ + 4 3 8 A 5.2 4 48 1.375 
 41 Dinakar 37533 56 M IPWMI 120 80 
  
+ 
 
2 2 7 A 3.5 2.6 49 1.375 1 
42 Mohan 37542 45 M ASMI 104 62 + 
 
+ 
 
3 
  
D 5.2 4.3 35 1.375 1 
43 Muniammal 37683 59 F IPWMI 120 80 
    
1 2 6 A 4.6 3.4 50 1.25 1 
44 Ganesh 37694 53 M ASMI 130 80 
  
+ 
 
2 2 7 A 4.8 3.7 45 1.5625 2 
45 Nagalingam 37788 48 M ASMI 120 90 + 
 
+ 
 
1 2 6 A 4.6 3.7 39 1.25 1 
46 Perumal 37795 56 M IPWMI/RVMI 110 90 + 
 
+ + 1 2 6 A 4.8 3.8 39 1.375 1 
47 Varadhan 37807 55 M AWMI 150 100 + 
   
2 2 7 A 5.8 4.7 36 1.9375 2 
48 Gopinathan 38743 57 M AWMI 130 90 
  
+ 
 
3 3 6 A 4.9 4 35 1.5 1 
49 Kuppuswamy 38900 47 M ASMI 130 90 
  
+ 
 
2 2 6 A 5.3 4.4 38 2.375 
 50 Nagabooshnam 38908 44 M ASMI 150 100 
  
+ 
 
1 3 7 A 3.9 2.9 50 2.375 
 SBP –Systolic blood pressure, DBP – Diastolic blood pressure, DM – Diabetes, SHT – Systemic hypertension, SM – Smoking, HL – Hyperlipidemia,  ICCU – No 
of days in ICCU, HOSP – total no of days in hospital, A/D – Alive/Dead, LVEDD Left Ventricular End Diastolic Dimension, LVESD – Left Ventricular End Systolic 
Dimension, LVEF – Left Ventricular Ejection Fraction, RWMI – Regional Wall Motion Scoring Index, DD – Diastolic Dysfunction (grading). 
 
